BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

9 articles for RJ Aversa

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design and Discovery of N-(2-Methyl-5'-morpholino-6'-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3'-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers.EBI
Novartis Institutes For Biomedical Research
Structure-Based Drug Design of Novel, Potent, and Selective Azabenzimidazoles (ABI) as ATR Inhibitors.EBI
Novartis Institutes For Biomedical Research
Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-a]pyrazines as ATR Inhibitors.EBI
Novartis Institutes For Biomedical Research
Design and Discovery of EBI
Novartis Institutes For Biomedical Research
Indole derivatives and their use in neurodegenerative diseasesBDB
Merck Patent
Aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptorsBDB
Axovant Sciences
Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitorsBDB
Incyte
Glucagon receptor antagonist compounds, compositions containing such compounds and methods of useBDB
Merck Sharp & Dohme
Aggrecanase inhibitorsBDB
Eli Lilly